<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Virtual Press Office and PR Newswire: General Trade show news</title>
<link>https://stage.vporoom.com/tradeshownews/</link>
<description></description>
<item>
<title>/C O R R E C T I O N -- LEOTEK/</title>
<link>https://stage.vporoom.com/tradeshownews/2026-06-12-C-O-R-R-E-C-T-I-O-N-LEOTEK</link>
<description></description>
<pubDate>Fri, 12 Jun 2026 10:35:00 -0400</pubDate>
<guid>https://stage.vporoom.com/tradeshownews/2026-06-12-C-O-R-R-E-C-T-I-O-N-LEOTEK</guid>
<enclosure url="https://mmx.prnewswire.com/media/MS1863788/image.jpg?id=OA2703033&amp;p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Braeburn to Present Research at CPDD 2026 Annual Meeting, Including Data on Withdrawal Suppression and Real-World Treatment Retention in Patients With Opioid Use Disorder</title>
<link>https://stage.vporoom.com/tradeshownews/2026-06-12-Braeburn-to-Present-Research-at-CPDD-2026-Annual-Meeting,-Including-Data-on-Withdrawal-Suppression-and-Real-World-Treatment-Retention-in-Patients-With-Opioid-Use-Disorder</link>
<description></description>
<pubDate>Fri, 12 Jun 2026 09:00:00 -0400</pubDate>
<guid>https://stage.vporoom.com/tradeshownews/2026-06-12-Braeburn-to-Present-Research-at-CPDD-2026-Annual-Meeting,-Including-Data-on-Withdrawal-Suppression-and-Real-World-Treatment-Retention-in-Patients-With-Opioid-Use-Disorder</guid>
</item>
<item>
<title>GELITA Unveils Next-Generation Excipient Innovations at BIO International 2026 in San Diego</title>
<link>https://stage.vporoom.com/tradeshownews/2026-06-12-GELITA-Unveils-Next-Generation-Excipient-Innovations-at-BIO-International-2026-in-San-Diego</link>
<description></description>
<pubDate>Fri, 12 Jun 2026 08:34:00 -0400</pubDate>
<guid>https://stage.vporoom.com/tradeshownews/2026-06-12-GELITA-Unveils-Next-Generation-Excipient-Innovations-at-BIO-International-2026-in-San-Diego</guid>
<enclosure url="https://mmx.prnewswire.com/media/MS1862639/GELITA-MEDELLAPRO_and_VACCIPRO.jpg?id=OA2698883&amp;p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results</title>
<link>https://stage.vporoom.com/tradeshownews/2026-06-12-AbbVie-Presents-New-Data-at-EHA-2026-Congress-for-VENCLEXTA-R-VENCLYXTO-R-venetoclax-in-First-Line-Chronic-Lymphocytic-Leukemia-Highlighting-Long-Term-Treatment-Outcomes-for-Patients-Nine-Year-Results</link>
<description></description>
<pubDate>Fri, 12 Jun 2026 03:00:00 -0400</pubDate>
<guid>https://stage.vporoom.com/tradeshownews/2026-06-12-AbbVie-Presents-New-Data-at-EHA-2026-Congress-for-VENCLEXTA-R-VENCLYXTO-R-venetoclax-in-First-Line-Chronic-Lymphocytic-Leukemia-Highlighting-Long-Term-Treatment-Outcomes-for-Patients-Nine-Year-Results</guid>
</item>
<item>
<title>ARROW INDUSTRIAL SOLUTIONS AND MACHINE SAFETY SPECIALISTS TO EXHIBIT COMPREHENSIVE MACHINE RISK ASSESSMENT AND SAFEGUARDING SOLUTIONS AT ASSP SAFETY 2026</title>
<link>https://stage.vporoom.com/tradeshownews/2026-06-12-ARROW-INDUSTRIAL-SOLUTIONS-AND-MACHINE-SAFETY-SPECIALISTS-TO-EXHIBIT-COMPREHENSIVE-MACHINE-RISK-ASSESSMENT-AND-SAFEGUARDING-SOLUTIONS-AT-ASSP-SAFETY-2026</link>
<description></description>
<pubDate>Fri, 12 Jun 2026 01:00:00 -0400</pubDate>
<guid>https://stage.vporoom.com/tradeshownews/2026-06-12-ARROW-INDUSTRIAL-SOLUTIONS-AND-MACHINE-SAFETY-SPECIALISTS-TO-EXHIBIT-COMPREHENSIVE-MACHINE-RISK-ASSESSMENT-AND-SAFEGUARDING-SOLUTIONS-AT-ASSP-SAFETY-2026</guid>
</item>
</channel>
</rss>
